USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation P Palazón‐Riquelme, JD Worboys, J Green, A Valera, F Martín‐Sánchez, ... EMBO reports 19 (10), e44766, 2018 | 137 | 2018 |
The three cytokines IL-1β, IL-18, and IL-1α share related but distinct secretory routes VS Tapia, MJD Daniels, P Palazón-Riquelme, M Dewhurst, NM Luheshi, ... Journal of Biological Chemistry 294 (21), 8325-8335, 2019 | 72 | 2019 |
The inflammasomes, immune guardians at defence barriers P Palazon‐Riquelme, G Lopez‐Castejon Immunology 155 (3), 320-330, 2018 | 45 | 2018 |
Pathophysiology of NSAID-associated intestinal lesions in the rat: luminal bacteria and mucosal inflammation as targets for prevention R Colucci, C Pellegrini, M Fornai, E Tirotta, L Antonioli, E Ghelardi, ... Frontiers in pharmacology 9, 388233, 2018 | 42 | 2018 |
Prodromal intestinal events in Alzheimer’s disease (AD): colonic dysmotility and inflammation are associated with enteric AD-related protein deposition C Pellegrini, S Daniele, L Antonioli, L Benvenuti, V D’antongiovanni, ... International Journal of Molecular Sciences 21 (10), 3523, 2020 | 24 | 2020 |
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet‐induced obesity C Pellegrini, M Fornai, L Benvenuti, R Colucci, V Caputi, ... British Journal of Pharmacology 178 (19), 3924-3942, 2021 | 9 | 2021 |
Method to measure ubiquitination of NLRs P Palazón-Riquelme, G López-Castejón NLR Proteins: Methods and Protocols, 223-229, 2016 | 5 | 2016 |
Method to Measure Ubiquitination of NLRs JD Worboys, P Palazón-Riquelme, G López-Castejón NLR Proteins: Methods and Protocols, 105-114, 2023 | | 2023 |
Rifaximin prevents diclofenac-induced enteropathy in rats through antibacterial and anti-inflammatory activities M Fornai, R Colucci, C Pellegrini, E Tirotta, L Antonioli, C Renzulli, ... Proceedings for Annual Meeting of The Japanese Pharmacological Society …, 2018 | | 2018 |